MDxHealth (MDXH) Common Equity (2020 - 2025)

MDxHealth has disclosed Common Equity across 6 years of filings, most recently posting -$12.1 million for Q4 2025.

• Common Equity for Q4 2025 came in at -$12.1 million, down 181.49% year-over-year; the trailing twelve-month figure through Dec 2025 was -$12.1 million (down 181.49% YoY), and the FY2025 annual result was -$12.1 million, down 181.49% from the prior year.
• Common Equity came in at -$12.1 million for Q4 2025 at MDxHealth, down from $9.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $46.9 million in Q4 2021 to a low of -$12.1 million in Q4 2025.
• The 5-year median for Common Equity is $9.2 million (2022), against an average of $12.5 million.
• Across the five-year window, Common Equity jumped 701.83% in 2021 and plunged 181.49% in 2025, its largest moves.
• MDxHealth's Common Equity stood at $46.9 million in 2021, then plunged by 80.14% to $9.3 million in 2022, then declined by 22.62% to $7.2 million in 2023, then jumped by 105.9% to $14.8 million in 2024, then slumped by 181.49% to -$12.1 million in 2025.
• The last three Common Equity figures came in at -$12.1 million (Q4 2025), $9.0 million (Q2 2025), and $14.8 million (Q4 2024), per Business Quant data.